ECM
ExodusPoint Capital Management Portfolio holdings
AUM
$8.21B
1-Year Return
14.38%
This Quarter Return
+9.03%
1 Year Return
+14.38%
3 Year Return
+47.96%
5 Year Return
+100.26%
10 Year Return
–
AUM
$8.09B
AUM Growth
+$49.3M
(+0.61%)
Cap. Flow
-$401M
Cap. Flow
% of AUM
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
23.13%
Holding
1,971
New
615
Increased
365
Reduced
343
Closed
617
Top Buys
| 1 |
NVIDIA
NVDA
|
+$451M |
| 2 |
Meta Platforms (Facebook)
META
|
+$204M |
| 3 |
Exxon Mobil
XOM
|
+$114M |
| 4 |
Duke Energy
DUK
|
+$106M |
| 5 |
Intel
INTC
|
+$65.9M |
Top Sells
| 1 |
Fidelity National Information Services
FIS
|
+$399M |
| 2 |
Constellation Brands
STZ
|
+$124M |
| 3 |
CMS Energy
CMS
|
+$124M |
| 4 |
Microsoft
MSFT
|
+$88.1M |
| 5 |
Global Payments
GPN
|
+$87.5M |
Sector Composition
| 1 | Technology | 19.24% |
| 2 | Utilities | 11.59% |
| 3 | Healthcare | 11.11% |
| 4 | Industrials | 10.65% |
| 5 | Real Estate | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
National CineMedia
NCMI
$455M
| $281K | ﹤0.01% |
54,582
-25,171
| -32% | -$130K |
|
1152
Allient
ALNT
$779M
| $280K | ﹤0.01% |
7,861
-2,313
| -23% | -$82.4K |
|
1153
Beam Therapeutics
BEAM
$2.08B
| $280K | ﹤0.01% |
+8,475
| New | +$280K |
|
1154
Cullinan Oncology
CGEM
$386M
| $279K | ﹤0.01% |
16,347
-13,290
| -45% | -$227K |
|
1155
National Vision
EYE
$1.82B
| $279K | ﹤0.01% |
+12,571
| New | +$279K |
|
1156
Ingevity
NGVT
$2.12B
| $278K | ﹤0.01% |
+5,829
| New | +$278K |
|
1157
FibroBiologics
FBLG
$22.7M
| $277K | ﹤0.01% |
+25,591
| New | +$277K |
|
1158
E.W. Scripps
SSP
$257M
| $276K | ﹤0.01% |
+70,197
| New | +$276K |
|
|
SLRN
1159
DELISTED
ACELYRIN
SLRN
| $273K | ﹤0.01% |
+40,381
| New | +$273K |
|
|
DQ
1160
Daqo New Energy
DQ
$1.73B
| $272K | ﹤0.01% |
+9,678
| New | +$272K |
|
1161
Olympic Steel
ZEUS
$368M
| $271K | ﹤0.01% |
+3,822
| New | +$271K |
|
|
PMT
1162
PennyMac Mortgage Investment
PMT
$1.07B
| $269K | ﹤0.01% |
+18,324
| New | +$269K |
|
1163
TransUnion
TRU
$17.9B
| $269K | ﹤0.01% |
+3,371
| New | +$269K |
|
1164
ATS Corp
ATS
$2.63B
| $268K | ﹤0.01% |
+7,961
| New | +$268K |
|
1165
Canadian Imperial Bank of Commerce
CM
$73.6B
| $268K | ﹤0.01% |
+5,286
| New | +$268K |
|
1166
NovaGold Resources
NG
$2.82B
| $268K | ﹤0.01% |
+89,206
| New | +$268K |
|
|
ENFN
1167
DELISTED
Enfusion, Inc.
ENFN
| $268K | ﹤0.01% |
+28,926
| New | +$268K |
|
1168
Inotiv
NOTV
$48.4M
| $267K | ﹤0.01% |
+24,412
| New | +$267K |
|
1169
Privia Health
PRVA
$2.8B
| $267K | ﹤0.01% |
13,604
-40,278
| -75% | -$791K |
|
1170
Cibus
CBUS
$71.5M
| $265K | ﹤0.01% |
+11,806
| New | +$265K |
|
1171
CVRx
CVRX
$205M
| $263K | ﹤0.01% |
14,463
+4,322
| +43% | +$78.6K |
|
|
PRSU
1172
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.04B
| $263K | ﹤0.01% |
+6,660
| New | +$263K |
|
1173
ALX Oncology
ALXO
$56.8M
| $261K | ﹤0.01% |
23,366
-7,025
| -23% | -$78.5K |
|
|
JBGS
1174
JBG SMITH
JBGS
$1.45B
| $258K | ﹤0.01% |
+16,080
| New | +$258K |
|
1175
Immatics
IMTX
$707M
| $257K | ﹤0.01% |
+24,437
| New | +$257K |
|